Log In
BCIQ
Print this Print this
 

MicardisPlus

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionCombination of 80 mg telmisartan angiotensin receptor blocker plus 12.5 mg hydrochlorothiazide calcium channel blocker
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Calcium channel
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat essential hypertension; Treat isolated systolic hypertension (ISH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today